(Reuters Health) - The shingles vaccine might not be cost-effective for people in their fifties, a new analysis suggests.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49a5987b/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A70Cus0Ehealth0Eshingles0Evaccine0Ecost0EidUSKCN0AR729X20A150A90A70DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
No comments:
Post a Comment